How to buy Beyond Air stock (XAIR)

Beyond Air is a medical devices business based in the US. Beyond Air shares (XAIR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.44 – an increase of 9.18% over the previous week. Beyond Air employs 107 staff and has a trailing 12-month revenue of around $1.8 million.

Our top picks for where to buy Beyond Air stock

Buy Beyond Air stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Beyond Air stock price (NASDAQ: XAIR)

Use our graph to track the performance of XAIR stocks over time.

Beyond Air shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.44
52-week range	$0.30 - $2.17
50-day moving average more info button	$0.47
200-day moving average more info button	$0.79
Wall St. target price	$2.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.41

Is it a good time to buy Beyond Air stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Beyond Air price performance over time

Historical closes compared with the close of $0.449 from 2024-12-26

1 week (2024-12-20)	11.41%
1 month (2024-11-27)	-20.67%
3 months (2024-09-27)	23.35%
6 months (2024-06-27)	-22.59%

1 year (2023-12-27)	-79.31%
2 years (2022-12-27)	-92.40%
3 years (2021-12-27)	9.45
5 years (2019-12-27)	4.38

Beyond Air financials

Revenue TTM	$1.8 million
Gross profit TTM	$873,190
Return on assets TTM	-63.48%
Return on equity TTM	-219.18%
Profit margin	0%
Book value	$0.55
Market Capitalization more info button	$30.4 million

TTM: trailing 12 months

Beyond Air share dividends

We're not expecting Beyond Air to pay a dividend over the next 12 months.

Have Beyond Air's shares ever split?

Beyond Air's shares were split on a 1:100 basis on 9 January 2017 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Beyond Air shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Beyond Air shares which in turn could have impacted Beyond Air's share price.

Beyond Air share price volatility

Over the last 12 months, Beyond Air's shares have ranged in value from as little as $0.296 up to $2.17. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Beyond Air's is -0.182. This would suggest that Beyond Air's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Beyond Air has bucked the trend.

Beyond Air overview

Beyond Air, Inc. , a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions.

Frequently asked questions

null
What percentage of Beyond Air is owned by insiders or institutions?
Currently 16.358% of Beyond Air shares are held by insiders and 36.398% by institutions. How many people work for Beyond Air?
Latest data suggests 107 work at Beyond Air. When does the fiscal year end for Beyond Air?
Beyond Air's fiscal year ends in March. Where is Beyond Air based?
Beyond Air's address is: 900 Stewart Avenue, Garden City, NY, United States, 11530 What is Beyond Air's ISIN number?
Beyond Air's international securities identification number is: US08862L1035 What is Beyond Air's CUSIP number?
Beyond Air's Committee on Uniform Securities Identification Procedures number is: 08862L103